Bioline International Official Site (site up-dated regularly)
8. Calculation of Doses- Patient Parameters.ppt [相容模式]
Body Surface Area Calculations Nursing Review
8. Calculation of Doses- Patient Parameters.ppt [相容模式]
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies | SpringerLink
Calculations of Doses
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study | SpringerLink
PDF) How to calculate the dose of chemotherapy
Carboplatin and Paclitaxel Carcinoma of Unknown Primary (CUP)
Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism | Cell Death Discovery
Dosage Calculations | Basicmedical Key
Carboplatin Dosing in Overweight and Obese Patients: A Single-Center Experience
EU Dosing App APK for Android Download
EU Dosing App APK for Android Download
How to calculate the dose of chemotherapy | British Journal of Cancer
Paclitaxel | CAS:33069-62-4 | Antineoplastic agent | Diterpenoids | High Purity | Manufacturer BioCrick
Effect of body mass index on pharmacokinetics of paclitaxel in patients with early breast cancer - Gota - 2021 - Cancer Medicine - Wiley Online Library
A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer - ScienceDirect
Paclitaxel | C47H51NO14 - PubChem
160-Breast adjuvant PACLitaxel dose dense | eviQ
Randomized study of individualized pharmacokinetically‐guided dosing of paclitaxel compared with body‐surface area dosing in Chinese patients with advanced non‐small cell lung cancer - Zhang - 2019 - British Journal of Clinical Pharmacology -
Taxol (paclitaxel) dosing, indications, interactions, adverse effects, and more
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer | Journal for ImmunoTherapy of Cancer
